Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GRANULOCYTE COLONY-STIMULATING FACTOR NOS for Stem cell therapy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 62 adverse event reports in the FDA FAERS database where GRANULOCYTE COLONY-STIMULATING FACTOR NOS was used for Stem cell therapy.

Most Reported Side Effects for GRANULOCYTE COLONY-STIMULATING FACTOR NOS

Side Effect Reports % Deaths Hosp.
Febrile neutropenia 350 15.9% 65 81
Product use in unapproved indication 192 8.7% 51 32
Haematotoxicity 186 8.5% 20 0
Off label use 169 7.7% 59 50
Death 167 7.6% 167 7
Neutropenia 157 7.1% 27 33
Sepsis 134 6.1% 71 53
Thrombocytopenia 134 6.1% 29 17
Pyrexia 125 5.7% 23 51
Disease progression 119 5.4% 73 9
Mucosal inflammation 100 4.6% 39 28
Diarrhoea 94 4.3% 22 18
Pneumonia 87 4.0% 29 35
Drug ineffective 81 3.7% 30 21
Anaemia 79 3.6% 11 16

Other Indications for GRANULOCYTE COLONY-STIMULATING FACTOR NOS

Acute myeloid leukaemia (344) Product used for unknown indication (249) Prophylaxis (198) Neutropenia (117) Acute lymphocytic leukaemia (102) Peripheral blood stem cell apheresis (66) Diffuse large b-cell lymphoma (54) Haematopoietic stem cell mobilisation (51) Bone marrow conditioning regimen (49) B-cell lymphoma (40)

Other Drugs Used for Stem cell therapy

LENALIDOMIDE (6) METFORMIN (6)

Related Pages

GRANULOCYTE COLONY-STIMULATING FACTOR NOS Full Profile All Stem cell therapy Drugs GRANULOCYTE COLONY-STIMULATING FACTOR NOS Demographics GRANULOCYTE COLONY-STIMULATING FACTOR NOS Timeline